|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2200056571 |
|
最近更新日期: Date of Last Refreshed on: |
2022-10-05 16:56:53 |
|
注册时间: Date of Registration: |
2022-02-08 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
激痛点刺络拔罐治疗中风后肩痛的临床观察 |
|
Public title: |
Clinical observation of stimulating point pricking and cupping in the treatment of shoulder pain after stroke |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
激痛点刺络拔罐治疗中风后肩痛的临床观察 |
|
Scientific title: |
Clinical observation of stimulating point pricking and cupping in the treatment of shoulder pain after stroke |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
ChiMCTR2200005623 |
|
申请注册联系人: |
张佩琴 |
研究负责人: |
佘畅 |
|
Applicant: |
Zhang Peiqin |
Study leader: |
She Chang |
|
申请注册联系人电话: Applicant telephone: |
+86 18229857146 |
研究负责人电话:
Study leader's |
+86 13397517289 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
1099081654@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
150645969@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
湖南省长沙市长沙县星沙大道长沙市中医医院 |
研究负责人通讯地址: |
湖南省长沙市长沙县星沙大道长沙市中医医院 |
|
Applicant address: |
Xingsha Avenue, Changsha County, Changsha, Hu'nan |
Study leader's address: |
Xingsha Avenue, Changsha County, Changsha, Hu'nan |
|
申请注册联系人邮政编码: Applicant postcode: |
410100 |
研究负责人邮政编码: Study leader's postcode: |
410100 |
|
申请人所在单位: |
湖南中医药大学 |
||
|
Applicant's institution: |
Hu'nan University of Traditional Chinese Medicine |
||
|
研究负责人所在单位: |
长沙市中医医院(长沙市第八医院) |
||
|
Affiliation of the Leader: |
Changsha Hospital of Traditional Chinese Medicine (the Eighth Hospital of Changsha) |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2022009 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
长沙市中医医院伦理委员会 |
||
|
Name of the ethic committee: |
Changsha Hospital of Traditional Chinese Medicine Ethics Committee |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2022-01-24 00:00:00 | ||
|
伦理委员会联系人: |
沈华 |
||
|
Contact Name of the ethic committee: |
Shen Hua |
||
|
伦理委员会联系地址: |
湖南省长沙市长沙县星沙大道长沙市中医医院 |
||
|
Contact Address of the ethic committee: |
Xingsha Avenue, Changsha County, Changsha, Hu'nan |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 13875938989 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
1099081654@qq.com |
|
研究实施负责(组长)单位: |
长沙市中医医院(长沙市第八医院) |
||||||||||||||||||||||
|
Primary sponsor: |
Changsha Hospital of Traditional Chinese Medicine (the Eighth Hospital of Changsha) |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
湖南省长沙市长沙县星沙大道长沙市中医医院 |
||||||||||||||||||||||
|
Primary sponsor's address: |
Xingsha Avenue, Changsha County, Changsha, Hu'nan |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹 |
||||||||||||||||||||||
|
Source(s) of funding: |
Self-financing |
||||||||||||||||||||||
|
研究疾病: |
中风后肩痛 |
||||||||||||||||||||||
|
Target disease: |
Hemiplegic Shoulder Pain |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
本研究结合临床实践及相关研究,着眼于刺络拔罐的镇痛作用及激痛点作用特点,探索一种新的方法激痛点刺络拔罐治疗中风后肩痛,以期减轻患者痛苦,降低致残率,减轻家庭和社会负担,也为临床治疗中风后肩痛提供新的思思路。 |
||||||||||||||||||||||
|
Objectives of Study: |
In this study, combined with clinical practice and related research, focusing on the analgesic effect and pain point characteristics of collateral puncture and cupping, a new method was explored for the treatment of shoulder pain after stroke, in order to reduce the pain and disability rate of patients and reduce the burden of family and society. it also provides new ideas for clinical treatment of shoulder pain after stroke. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.符合中风病的中西医诊断标准; |
||||||||||||||||||||||
|
Inclusion criteria |
1. In line with the diagnostic criteria of traditional Chinese and western medicine for stroke; 2. The age is between 40 and 75 years old; 3. The recovery period of stroke (the course of disease ranges from 2 weeks to 6 months); 4. Suffering from hemiplegia and hemiplegic upper limb shoulder pain (VAS score 4-6 moderate pain), hemiplegic upper limb muscle strength was Ⅱ-Ⅳ; 5. Unconscious disorder and aphasia, etc., can cooperate with examination and treatment; 6. The blood coagulation function was normal and there was no serious organic disease. Volunteer to participate in this study and sign an informed consent form. |
||||||||||||||||||||||
|
排除标准: |
排除标准 |
||||||||||||||||||||||
|
Exclusion criteria: |
Exclusion criteria 1. Patients with shoulder pain and dyskinesia before stroke, such as scapulohumeral periarthritis, fracture, etc. Patients with severe heart, liver, kidney and metabolic diseases, mental illness and tumor; 3. The expected survival time is less than 3 months; 4. There is a disturbance of consciousness; 5. Severe dizziness can not be tolerated; 6. Pregnant, planned or lactating women; 7. Participated in clinical trials of other drugs in the past one month. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2022-01-24 00:00:00至 To 2023-01-24 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2022-02-15 00:00:00 至 To 2022-09-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
根据就诊顺序,将符合纳入标准的病例按随机数字表,将写有随机分组数字的卡片置于信封密封。符合纳入标准的受试者随机抽取信封,按信封内的随机数字随机分成2组,观察组(激痛点刺络拔罐+常规针刺组),和对照组(常规针刺组治疗)。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
According to the order of medical treatment, the cases that meet the inclusion criteria are listed according to the random number table, and the cards with randomly grouped numbers are sealed in the envelope. The subjects who met the inclusion criteria randomly selected envelopes and randomly divided them i |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
|
|
Blinding: |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
- |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
- |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
- |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
- |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |